L-Lactic Acid

L-Lactic Acid

SCHEMBL1229932

CC(O)C(=O)[O-].CC(O)C(=O)[O-].O.O.[Zn+2]

nearest known ligand 0.86

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CHRM1DRD2DRD3DRD4HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR2APDE3ASIGMAR1SLC9A3

The experimentally established mechanism targets of L-Lactic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.47
CA1 P00915 4/20 0.38
CA4 P22748 3/20 0.36
CA2 P00918 1/20 0.36
CYP3A4 P08684 2/20 0.35
TSHR P16473 2/20 0.35
NFKB1 P19838 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
L-Lactic Acid SCHEMBL29401074 1.00 TP53 (0.47) TP53CA1CA4CA2CYP3A4
L-Lactic Acid SCHEMBL15362198 1.00 TP53 (0.47) TP53CA1CA4CA2CYP3A4
L-Lactic Acid SCHEMBL435503 1.00 TP53 (0.47) TP53CA1CA4CA2CYP3A4
L-Lactic Acid SCHEMBL118974 0.96 TP53 (0.50) TP53CA1CA4CA2CYP3A4
L-Lactic Acid SCHEMBL29397605 0.96 TP53 (0.50) TP53CA1CA4CA2CYP3A4
L-Lactic Acid SCHEMBL29397432 0.96 TP53 (0.50) TP53CA1CA4CA2CYP3A4
L-Lactic Acid SCHEMBL28619730 0.96 TP53 (0.50) TP53CA1CA4CA2CYP3A4
L-Lactic Acid SCHEMBL975525 0.96 TP53 (0.50) TP53CA1CA4CA2CYP3A4
L-Lactic Acid SCHEMBL25270068 0.93
L-Lactic Acid SCHEMBL8462013 0.93

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 198 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4687485-A1 NOVEL COMBINATIONS COMPRISING KONJAC MANNAN, THEIR COMPOSITIONS AND USES THEREOF Vivatis Pharma GmbH (DE) 2026-02-11 EP claimed
EP-4687486-A1 NOVEL COMBINATIONS COMPRISING KONJAC MANNAN, THEIR COMPOSITIONS AND USES THEREOF Vivatis Pharma GmbH (DE) 2026-02-11 EP claimed
CN-119792104-A Oral care compositions 高露洁-棕榄公司 2025-04-11 CN claimed
WO-2024201327-A1 NOVEL COMBINATIONS COMPRISING KONJAC MANNAN, THEIR COMPOSITIONS AND USES THEREOF VIVATIS PHARMA GMBH (DE) 2024-10-03 WO claimed
WO-2024201329-A1 NOVEL COMBINATIONS COMPRISING KONJAC MANNAN, THEIR COMPOSITIONS AND USES THEREOF VIVATIS PHARMA GMBH (DE) 2024-10-03 WO claimed
US-11440852-B2 Seed, soil, and plant treatment compositions RALCO NUTRITION, INC. (US) 2022-09-13 US claimed
US-20220133607-A1 Oral Care Composition COLGATE-PALMOLIVE COMPANY (US) 2022-05-05 US claimed
US-11253444-B2 Oral care composition COLGATE-PALMOLIVE COMPANY (US) 2022-02-22 US claimed
WO-2021025993-A1 SEED, SOIL, AND PLANT TREATMENT COMPOSITIONS RALCO NUTRITION, INC. (US) 2021-02-11 WO claimed
US-20210032174-A1 SEED, SOIL, AND PLANT TREATMENT COMPOSITIONS RALCO NUTRITION INC (US) 2021-02-04 US claimed
US-20190209448-A1 An Oral Care Composition COLGATE-PALMOLIVE COMPANY (US) 2019-07-11 US claimed
EP-3461262-A1 AN ORAL CARE COMPOSITION Colgate-Palmolive Company (US) 2019-04-03 EP claimed
CN-109328092-A Oral care compositions 高露洁-棕榄公司 2019-02-12 CN claimed
WO-2017222548-A1 AN ORAL CARE COMPOSITION COLGATE-PALMOLIVE COMPANY (US) 2017-12-28 WO claimed
WO-2004080210-A1 COMPOSITIONS OF DIETARY METALS FOR SUPPORT OF THE PHYSIOLOGICAL INTESTINAL DEVELOPMENT AND PREVENTION OF DIARRHOEA BOEHRINGER INGELHEIM DANMARK A/S (DK) 2004-09-23 WO claimed
EP-3773453-B1 ORAL CARE COMPOSITIONS FOR PROMOTING GUM HEALTH PROCTER & GAMBLE (US) 2026-04-01 EP disclosed
EP-4037638-B1 ORAL CARE COMPOSITIONS COMPRISING STANNOUS ION SOURCE, NEUTRAL AMINO ACID, AND POLYPHOSPHATE PROCTER & GAMBLE (US) 2026-04-01 EP disclosed
US-6685920-B2 POLYMERIC MINERAL SURFACE-ACTIVE AGENT IS CONDENSED PHOSPHORYLATED POLYMERS; A DIPHOSPHONATE MODIFIED POLYACRYLIC ACID THE PROCTER & GAMBLE COMPANY 2004-02-03 US disclosed
EP-1227735-B1 CHEWING GUM COMPOSITIONS PROCTER & GAMBLE (US) 2003-10-22 EP disclosed
US-6534560-B2 Crosslinking SCIMED LIFE SYSTEMS, INC. 2003-03-18 US disclosed